No one ever explained and yet the stock have never hit 2.11 since.
the stock was 3.40 upon FDA approval in march 2013, then Larson valued the company at 2.11 for a reason no one has ever explained when the fools realized the loan covenants and over spending on worthless pipeline products like 5001 would put them in a precarious cashposition, hence the Crede deal was borne and cratered the stockwhich never recovered.
FACTS ARE FACTS the stock has not achieved 2.11 since.
it is not up 10% for the year opened at 33.98, I guess if you add back the dividend but who expected to lose the whole years gains in a short period
years and years later still under a buck what a disaster, blame Platinum they will milk this until there is a billion shares outstanding and they will make $$$$$$ from it
you've been pumping a dead horse for a decade stock is 1.60 still, those are the facts and you never admit the company #$%$ ups are what caused the stock price to flounder
Paly the paster, the stock is still 1.60????
I am sure they will blow the cash break even and move the goalpost once again
not 10 million 3 years later
That is ancient history, in March 2013 upon FDA approval the stock was 3.40, now it is more than 50% less, not exactly numbers to be boasting about.
When has navidea's management ever negotiated a good deal with another company??????? Cardinal???? Crede???? Norgene?????? Do you really believe Amgen like company would partner with NAVB?????? You need to lay off the crack.